Short- and long-term effects on prolactin of risperidone and olanzapine treatments in children and adolescents
- 1 November 2009
- journal article
- clinical trial
- Published by Elsevier in Progress in Neuro-Psychopharmacology and Biological Psychiatry
- Vol. 33 (8) , 1496-1501
Abstract
No abstract availableKeywords
This publication has 29 references indexed in Scilit:
- Effectiveness and Tolerability of Olanzapine in the Treatment of Adolescents with Schizophrenia and Related Psychotic Disorders: Results from a Large, Prospective, Open-Label StudyJournal of Child and Adolescent Psychopharmacology, 2008
- Prolactin Release in Children Treated With RisperidoneJournal of Clinical Psychopharmacology, 2007
- Elevated Prolactin Levels in Male Youths Treated with Risperidone and QuetiapineJournal of Child and Adolescent Psychopharmacology, 2005
- Risperidone-Induced Prolactin Elevation in a Prospective Study of Children, Adolescents, and Adults with Mental Retardation and Pervasive Developmental DisordersJournal of Child and Adolescent Psychopharmacology, 2005
- The Effect of Atypical Antipsychotic Agents on Prolactin Levels in Children and AdolescentsJournal of Child and Adolescent Psychopharmacology, 2004
- Antipsychotic-Induced HyperprolactinaemiaDrugs, 2004
- Correlation of Antipsychotic and Prolactin Concentrations in Children and Adolescents Acutely Treated with Haloperidol, Clozapine, or OlanzapineJournal of Child and Adolescent Psychopharmacology, 2002
- Elevated Prolactin in Pediatric Patients on Typical and Atypical AntipsychoticsJournal of Child and Adolescent Psychopharmacology, 1999
- A STUDY OF SERUM PROLACTIN LEVELS IN SCHIZOPHRENIA: COMPARISON OF MALES AND FEMALESClinical and Experimental Pharmacology and Physiology, 1992
- Lack of tolerance to long‐term neuroleptic treatment in dopamine tuberoinfundibular systemActa Psychiatrica Scandinavica, 1981